The Enterprise Value as of March 2025 (TTM) for Imunon, Inc. (IMNN) is 1.15B

According to Imunon, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.15B. This represents a change of 289.87% compared to the average of 293.96M of the last 4 quarters.

Imunon, Inc. (IMNN) Historical Enterprise Value (quarterly & annually)

How has IMNN Enterprise Value performed in the past?

The mean historical Enterprise Value of Imunon, Inc. over the last ten years is 131.57M. The current 1.15B Enterprise Value has changed 87.01% with respect to the historical average. Over the past ten years (40 quarters), IMNN's Enterprise Value was at its highest in in the December 2024 quarter at 1.14B. The Enterprise Value was at its lowest in in the September 2022 quarter at -8648647.12.

Imunon, Inc. (IMNN) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Imunon, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Imunon, Inc. (IMNN) Average Enterprise Value

How has IMNN Enterprise Value performed in the past?

The current Enterprise Value of Imunon, Inc. (IMNN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Imunon, Inc. (IMNN) Enterprise Value vs. Peers

How is IMNN’s Enterprise Value compared to its peers?

Imunon, Inc.’s Enterprise Value is greater than Exicure, Inc. (39.22M), greater than Cyclacel Pharmaceuticals, Inc. (361.06K), greater than Histogen Inc. (-4487565.00), greater than DiaMedica Therapeutics Inc. (242.96M), greater than Neoleukin Therapeutics, Inc. (-6333315.00), greater than Senti Biosciences, Inc. (41.08M), greater than Hillstream BioPharma, Inc. (1.48M), greater than SAB Biotherapeutics, Inc. (10.21M), greater than Quoin Pharmaceuticals, Ltd. (-3620851544.00), greater than SAB Biotherapeutics, Inc. (10.21M), greater than Cingulate Inc. (1.73M), greater than Bellicum Pharmaceuticals, Inc. (-5130674.00), greater than Lisata Therapeutics, Inc. (4.53M), greater than Lixte Biotechnology Holdings, Inc. (1.61M), greater than Kineta, Inc. (6.78M), greater than Theriva Biologics, Inc. (-6925053.00), greater than Lumos Pharma, Inc. (24.19M), greater than Diffusion Pharmaceuticals Inc. (45.41M), greater than Avalo Therapeutics, Inc. (-3981996.00), greater than Catalyst Biosciences, Inc. (1.04B),

Build a custom stock screener for Imunon, Inc. (IMNN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Imunon, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Imunon, Inc. (IMNN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Imunon, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.